This week, Saudi Arabia’s Crown Prince Mohammed bin Salman promises to bring as much as $1 trillion in investment to the US as Saudi Arabia tries to pivot from oil towards becoming a global technology and investment player. And, from small-town Michigan to the headquarters of Walmart, we reveal how philanthropy, volunteering and community ties power America’s hidden generosity. Plus, what’s driving the US’s power grid strain? Later, McLaren’s Zak Brown reveals what it really takes to build a winning culture and why great leaders never get comfortable at the top.

See omnystudio.com/listener for privacy information.

This week, Santander’s Ana Botín is steering one of Europe’s biggest banks through red tape and rising taxes. She says that growth, not regulation, is what Europe needs most. And, quantum mechanics is driving a multibillion-dollar race. The technology is already in use, but measuring success is the next challenge for investors. Plus, the Netherlands is offering a blueprint for how pension systems around the world adapt. Later, can Finland’s plan to turn data center heat into clean power work worldwide?

See omnystudio.com/listener for privacy information.

This week, can Congress delegate its authority over trade and tariffs to the president? The Supreme Court questioned the Trump Administration’s argument that a statute passed by Congress gives the president the power to impose worldwide tariffs. But if the Court disagrees with the administration, who pays - and how much? And, New York City’s mayor-elect Zohran Mamdani vows to make the city more affordable, but business leaders say that it’s more complicated than it seems. Plus, Health and Human Services Secretary RFK Jr. claims doctors are reaping big profits from vaccines, but pediatricians say that’s far from the truth: high costs of running a practice, low reimbursement rates, and misinformation are pushing pediatricians to the brink. Later, why are Americans eating so much protein? President Trump reached a deal with drugmakers Eli Lilly and Novo Nordisk to make GLP-1s more accessible to more of the American population, and protein producers - new and old - could stand to gain.

See omnystudio.com/listener for privacy information.